unknown
Stage
3
Investors
About
Congruence Therapeutics is a drug discovery company that combines protein dynamics, biophysics, machine learning and computational chemistry to develop predictive models and small-molecule correctors that restore proper protein function; its platform is referred to as the Revenir product engine.
Explore Congruence Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.